SSRI use in pregnancy: Evaluating the risks and benefits

被引：0
作者：
du Toit, E. [1 ]
Thomas, E. [2 ,3 ]
Koen, L. [2 ,3 ]
Vythilingum, B. [4 ]
Grobler, S. [5 ]
Smith, N. [5 ]
Niehaus, D. [2 ,3 ]
机构：
[1] Sophia Clin, Cape Town, South Africa
[2] Univ Stellenbosch, Maternal Mental Hlth Clin, Stikland Hosp, Cape Town, South Africa
[3] Univ Stellenbosch, Dept Psychiat, Fac Med & Hlth Sci, Cape Town, South Africa
[4] Univ Cape Town, Dept Psychiat, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa
[5] Walter Sisulu Univ, Dept Psychiat, Fac Hlth Sci, Mthatha, South Africa
来源：
SOUTH AFRICAN JOURNAL OF PSYCHIATRY | 2015年 / 21卷 / 02期
关键词：
SEROTONIN REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; IN-UTERO EXPOSURE; ALCOHOL SPECTRUM DISORDERS; ANTIDEPRESSANT USE; MATERNAL USE; INTERPERSONAL PSYCHOTHERAPY; ANTENATAL DEPRESSION; PRENATAL EXPOSURE; MAJOR DEPRESSION;
D O I：
10.7196/SAJP.587
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Selective serotonin reuptake inhibitor (SSRI) antidepressants are considered the primary pharmacological treatment for moderate to severe depression during pregnancy. Data regarding the safety of their use during pregnancy remain controversial and conflicting. Decisions regarding the prescription of antidepressant treatment are often fraught with concern around potential harmful medication effects on the pregnancy, fetus and infant. Information on potential risks remains extremely varied and inconsistent across sources. This lack of clarity regarding drug safety brings significant uncertainty not only for treating physicians, but also for women seeking information about depression during pregnancy. This review aims to summarise and evaluate the current evidence base and to aid clinicians in performing a risk/benefit analysis for SSRI use during pregnancy and lactation.
引用
收藏
页码：48 / 53
页数：6
相关论文
共 71 条
  • [1] [Anonymous], PUBL HLTH ADV PAR
  • [2] Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice
    Ansorge, MS
    Zhou, MM
    Lira, A
    Hen, R
    Gingrich, JA
    [J]. SCIENCE, 2004, 306 (5697) : 879 - 881
  • [3] First-Trimester Use of Paroxetine and Congenital Heart Defects: A Population-Based Case-Control Study
    Bakker, Marian K.
    Kerstjens-Frederikse, Wilhelmina S.
    Buys, Charles H. C. M.
    de Walle, Hermien E. K.
    de Jong-van den Berg, Lolkje T. W.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2010, 88 (02) : 94 - 100
  • [4] Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease
    Beral, V
    Bull, D
    Doll, R
    Peto, R
    Reeves, G
    La Vecchia, C
    Magnusson, C
    Miller, T
    Peterson, B
    Pike, M
    Thomas, D
    van Leeuwen, F
    [J]. LANCET, 2002, 360 (9328) : 187 - 195
  • [5] Antidepressant use in pregnancy: a critical review focused on risks and controversies
    Byatt, N.
    Deligiannidis, K. M.
    Freeman, M. P.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2013, 127 (02) : 94 - 114
  • [6] Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy
    Casper, RC
    Fleisher, BE
    Lee-Ancajas, JC
    Gilles, A
    Gaylor, E
    DeBattista, A
    Hoyme, HE
    [J]. JOURNAL OF PEDIATRICS, 2003, 142 (04) : 402 - 408
  • [7] Birth outcomes in pregnant women taking fluoxetine
    Chambers, CD
    Johnson, KA
    Dick, LM
    Felix, RJ
    Jones, KL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1010 - 1015
  • [8] Stress during gestation alters postpartum maternal care and the development of the offspring in a rodent model
    Champagne, Frances A.
    Meaney, Michael J.
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (12) : 1227 - 1235
  • [9] Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes
    Chung, TKH
    Lau, TK
    Yip, ASK
    Chiu, HFK
    Lee, DTS
    [J]. PSYCHOSOMATIC MEDICINE, 2001, 63 (05): : 830 - 834
  • [10] Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment
    Cohen, LS
    Altshuler, LL
    Harlow, BL
    Nonacs, R
    Newport, DJ
    Viguera, AC
    Suri, R
    Burt, VK
    Hendrick, V
    Reminick, AM
    Loughead, A
    Vitonis, AF
    Stowe, ZN
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05): : 499 - 507
12345678